Evidence map›Paper›PMID 42601506›Full record

ArticleEMBO reports2026

3D chromatin organisation contributes to the regulatory logic in differentiating lymphatic endothelium.

Virginia Panara, Hannah Arnold, Marleen Gloger, Renae Skoczylas, Victoria Vidal Gutierrez, Anna Johansson, Agata Smialowska, Katarzyna Koltowska

Abstract read
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Virginia Panara *Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Hannah Arnold *Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-4010-0124
Marleen Gloger *Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-3319-7642
Renae SkoczylasDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-8570-7368
Victoria Vidal GutierrezDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0009-0008-5938-8712
Anna JohanssonDepartment of Cell and Molecular Biology, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Agata SmialowskaDepartment of Biochemistry and Biophysics, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Stockholm University, Stockholm, Sweden.
Katarzyna KoltowskaDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. kaska.koltowska@igp.uu.se.ORCID http://orcid.org/0000-0002-6841-8900

Funding

Cancerfonden (Swedish Cancer Society) 20 1086 PjHelge Ax:son Johnsons Stiftelse Nr F25-0279Kjell och Märta Beijers Stiftelse (Beijers stiftelse) 2022Knut och Alice Wallenbergs Stiftelse (kawforskning) 2017.0144Knut och Alice Wallenbergs Stiftelse (kawforskning) 2022.0187Magnus Bergvalls Stiftelse 2024-1281Ragnar Söderbergs stiftelse (Ragnar Söderberg Foundation) M13/17Vetenskapsrådet (VR) VR-MH-2016-01437, Ã"RNT-2023-06503, VR-MH-2023-02459
6 · The paper itself

Abstract

Gene activation and repression is an integral part of embryonic development and tissue formation. Changes in chromatin organisation dictate accessibility to gene regulatory elements, controlling gene expression. Although several molecular regulators of lymphatic endothelial cell (LEC) development have been identified, the role of chromatin organisation in the acquisition of LEC identity remains unclear. In this study, we combine HiC and ATAC-sequencing to map 3D chromatin architecture and accessibility in LECs and blood endothelial cells (BECs). We identify cell type-specific topologically associating domains (TADs), and discovered TAD boundaries changes and differentially segregating enhancers in lymphatic-associated loci, such as prox1a and tbx1. Our multi-omic approach also defines the regulatory logic of nine LEC-enriched genes. In vivo validation of ATAC- and HiC-based enhancers confirms their activity in LECs. Leveraging these datasets, we reconstructed mafba tissue-specific regulatory networks identifying a genetic interaction with tfe3a in vivo limiting ectopic vessel formation. Overall, our work provides a powerful resource of multi-omic datasets that can be used to systematically determine the regulatory networks governing LEC identity and genes linked to lymphatic disease.

Indexed as

Cell DifferentiationChromatinEndothelium, LymphaticAnimalsEndothelial CellsEnhancer Elements, GeneticGene Expression Regulation, DevelopmentalGene Regulatory NetworksHomeodomain ProteinsHumansMiceProspero-Related Homeobox 1 ProteinChromatinHomeodomain ProteinsProspero-Related Homeobox 1 Protein

Identifiers

PMID42601506
PMCPMC13601605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.